These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8380762)

  • 1. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.
    Trang JM; Kidd L; Gruber W; Storch G; Demmler G; Jacobs R; Dankner W; Starr S; Pass R; Stagno S
    Clin Pharmacol Ther; 1993 Jan; 53(1):15-21. PubMed ID: 8380762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.
    Zhou XJ; Gruber W; Demmler G; Jacobs R; Reuman P; Adler S; Shelton M; Pass R; Britt B; Trang JM; Whitley RJ; Sommadossi JP
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2202-5. PubMed ID: 8878608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients.
    Anderson RD; Griffy KG; Jung D; Dorr A; Hulse JD; Smith RB
    Clin Ther; 1995; 17(3):425-32. PubMed ID: 7585846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot Study of Model-Based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection.
    Dong Q; Leroux S; Shi HY; Xu HY; Kou C; Khan MW; Jacqz-Aigrain E; Zhao W
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment.
    Asano-Mori Y; Kanda Y; Oshima K; Watanabe T; Shoda E; Motokura T; Kurokawa M; Chiba S
    J Antimicrob Chemother; 2006 May; 57(5):1004-7. PubMed ID: 16551692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.
    Acosta EP; Brundage RC; King JR; Sánchez PJ; Sood S; Agrawal V; Homans J; Jacobs RF; Lang D; Romero JR; Griffin J; Cloud G; Whitley R; Kimberlin DW;
    Clin Pharmacol Ther; 2007 Jun; 81(6):867-72. PubMed ID: 17392728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
    Kimberlin DW; Acosta EP; Sánchez PJ; Sood S; Agrawal V; Homans J; Jacobs RF; Lang D; Romero JR; Griffin J; Cloud GA; Lakeman FD; Whitley RJ;
    J Infect Dis; 2008 Mar; 197(6):836-45. PubMed ID: 18279073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.
    Brown F; Banken L; Saywell K; Arum I
    Clin Pharmacokinet; 1999 Aug; 37(2):167-76. PubMed ID: 10496303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of valganciclovir pharmacokinetics in lung transplant recipients.
    Kiser TH; Fish DN; Zamora MR
    J Heart Lung Transplant; 2012 Feb; 31(2):159-66. PubMed ID: 22305377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function.
    Sommadossi JP; Bevan R; Ling T; Lee F; Mastre B; Chaplin MD; Nerenberg C; Koretz S; Buhles WC
    Rev Infect Dis; 1988; 10 Suppl 3():S507-14. PubMed ID: 2847287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ganciclovir in a patient undergoing chronic haemodialysis.
    Combarnous F; Fouque D; Bernard N; Boulieu R; Chossegros P; Laville M; Zech P
    Eur J Clin Pharmacol; 1994; 46(4):379-81. PubMed ID: 7957527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ganciclovir in renal transplant children.
    Jacqz-Aigrain E; Macher MA; Sauvageon-Marthe H; Brun P; Loirat C
    Pediatr Nephrol; 1992 Mar; 6(2):194-6. PubMed ID: 1315149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.
    Czock D; Scholle C; Rasche FM; Schaarschmidt D; Keller F
    Clin Pharmacol Ther; 2002 Aug; 72(2):142-50. PubMed ID: 12189361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric expectation maximization population modeling of ganciclovir.
    Preston SL; Drusano GL
    J Clin Pharmacol; 1996 Apr; 36(4):301-10. PubMed ID: 8728343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units.
    Müller C; Kremer W; Harlfinger S; Doroshyenko O; Jetter A; Hering F; Hünseler C; Roth B; Theisohn M
    Eur J Pediatr; 2006 Apr; 165(4):229-39. PubMed ID: 16496200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny.
    Kearns GL; Robinson PK; Wilson JT; Wilson-Costello D; Knight GR; Ward RM; van den Anker JN;
    Clin Pharmacol Ther; 2003 Oct; 74(4):312-25. PubMed ID: 14534518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis.
    Swan SK; Munar MY; Wigger MA; Bennett WM
    Am J Kidney Dis; 1991 Jan; 17(1):69-72. PubMed ID: 1846060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients.
    Pescovitz MD; Ettenger RB; Strife CF; Sherbotie JR; Thomas SE; McDiarmid S; Bartosh S; Ives J; Bouw MR; Bucuvalas J
    Transpl Infect Dis; 2010 Jun; 12(3):195-203. PubMed ID: 20002356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Different dosages Ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal].
    Hong-Bin Z; Feng-Xian Z; Cai-Ping G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):57-9. PubMed ID: 22919757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and clearance of ganciclovir during continuous hemodiafiltration.
    Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
    Crit Care Med; 1998 Jan; 26(1):184-7. PubMed ID: 9428565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.